A subgroup analysis of the Warfarin Aspirin Symptomatic Intracranial Disease (WASID) trial showed no advantage of warfarin over aspirin for preventing the primary end point of ischemic stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback